Line | Cytokine | Population | Frequency (%) | Sample Size | Location |
---|---|---|---|---|---|
1 | IL-1beta/ -31CC | England South Cytokine | 13.4 | 260 | 51_0_N_1_3_W |
2 | IL-1beta/ -31CT | England South Cytokine | 46.3 | 260 | 51_0_N_1_3_W |
3 | IL-1beta/ -31TT | England South Cytokine | 40.3 | 260 | 51_0_N_1_3_W |
4 | IL-1beta/ -511 CC | England South Cytokine | 33.3 | 260 | 51_0_N_1_3_W |
5 | IL-1beta/ -511 CT | England South Cytokine | 51.7 | 260 | 51_0_N_1_3_W |
6 | IL-1beta/ -511 TT | England South Cytokine | 14.9 | 260 | 51_0_N_1_3_W |
7 | IL-2/ - 330 GG | England South Cytokine | 8.1 | 260 | 51_0_N_1_3_W |
8 | IL-2/ - 330 GT | England South Cytokine | 38.1 | 260 | 51_0_N_1_3_W |
9 | IL-2/ - 330 TT | England South Cytokine | 53.8 | 260 | 51_0_N_1_3_W |
10 | IL-4/ - 590 CC | England South Cytokine | 79.3 | 260 | 51_0_N_1_3_W |
11 | IL-4/ - 590 CT | England South Cytokine | 18.8 | 260 | 51_0_N_1_3_W |
12 | IL-4/ - 590 TT | England South Cytokine | 1.9 | 260 | 51_0_N_1_3_W |
13 | IL-6/ - 174 CC | England South Cytokine | 19.6 | 260 | 51_0_N_1_3_W |
14 | IL-6/ - 174 CG | England South Cytokine | 45.1 | 260 | 51_0_N_1_3_W |
15 | IL-6/ - 174 GG | England South Cytokine | 35.3 | 260 | 51_0_N_1_3_W |
16 | IL-10/ - 592 AA | England South Cytokine | 5.1 | 260 | 51_0_N_1_3_W |
17 | IL-10/ - 592 AC | England South Cytokine | 37.3 | 260 | 51_0_N_1_3_W |
18 | IL-10/ - 592 CC | England South Cytokine | 57.6 | 260 | 51_0_N_1_3_W |
19 | IL-10/ - 819 CC | England South Cytokine | 57.6 | 260 | 51_0_N_1_3_W |
20 | IL-10/ - 819 CT | England South Cytokine | 37.3 | 260 | 51_0_N_1_3_W |
21 | IL-10/ - 819 TT | England South Cytokine | 5.1 | 260 | 51_0_N_1_3_W |
22 | IL-10/ - 1082 AA | England South Cytokine | 20.6 | 260 | 51_0_N_1_3_W |
23 | IL-10/ - 1082 AG | England South Cytokine | 53.8 | 260 | 51_0_N_1_3_W |
24 | IL-10/ - 1082 GG | England South Cytokine | 25.6 | 260 | 51_0_N_1_3_W |
25 | IL-12/ - 1188 AA | England South Cytokine | 60.7 | 260 | 51_0_N_1_3_W |
26 | IL-12/ - 1188 AC | England South Cytokine | 33.6 | 260 | 51_0_N_1_3_W |
27 | IL-12/ - 1188 CC | England South Cytokine | 5.7 | 260 | 51_0_N_1_3_W |
28 | IFNgamma/ 874 AA | England South Cytokine | 31.1 | 260 | 51_0_N_1_3_W |
29 | IFNgamma/ 874 AT | England South Cytokine | 48.2 | 260 | 51_0_N_1_3_W |
30 | IFNgamma/ 874 TT | England South Cytokine | 20.7 | 260 | 51_0_N_1_3_W |
31 | TNFalpha/ - 238 AA | England South Cytokine | 0.0 | 260 | 51_0_N_1_3_W |
32 | TNFalpha/ - 238 AG | England South Cytokine | 21.8 | 260 | 51_0_N_1_3_W |
33 | TNFalpha/ - 238 GG | England South Cytokine | 78.2 | 260 | 51_0_N_1_3_W |
34 | TNFalpha/ - 308 AA | England South Cytokine | 5.9 | 260 | 51_0_N_1_3_W |
35 | TNFalpha/ - 308 AG | England South Cytokine | 25.9 | 260 | 51_0_N_1_3_W |
36 | TNFalpha/ - 308 GG | England South Cytokine | 68.2 | 260 | 51_0_N_1_3_W |
37 | TNFbeta/ 252 AA | England South Cytokine | 41.8 | 260 | 51_0_N_1_3_W |
38 | TNFbeta/ 252 AG | England South Cytokine | 37.7 | 260 | 51_0_N_1_3_W |
39 | TNFbeta/ 252 GG | England South Cytokine | 20.5 | 260 | 51_0_N_1_3_W |
40 | TGFbeta1/codon 25 CC | England South Cytokine | 0.6 | 260 | 51_0_N_1_3_W |
41 | TGFbeta1/codon 25 CG | England South Cytokine | 16.3 | 260 | 51_0_N_1_3_W |
42 | TGFbeta1/codon 25 GG | England South Cytokine | 83.1 | 260 | 51_0_N_1_3_W |
43 | EGF/ 61 AA | England South Cytokine | 39.0 | 260 | 51_0_N_1_3_W |
44 | EGF/ 61 AG | England South Cytokine | 42.3 | 260 | 51_0_N_1_3_W |
45 | EGF/ 61 GG | England South Cytokine | 18.7 | 260 | 51_0_N_1_3_W |
46 | VEGF/ -1154 AA | England South Cytokine | 12.9 | 260 | 51_0_N_1_3_W |
47 | VEGF/ -1154 AG | England South Cytokine | 41.5 | 260 | 51_0_N_1_3_W |
48 | VEGF/ -1154 GG | England South Cytokine | 45.6 | 260 | 51_0_N_1_3_W |
49 | VEGF/ -2578 AA | England South Cytokine | 26.0 | 260 | 51_0_N_1_3_W |
50 | VEGF/ -2578 AC | England South Cytokine | 43.2 | 260 | 51_0_N_1_3_W |
51 | VEGF/ -2578 CC | England South Cytokine | 30.8 | 260 | 51_0_N_1_3_W |